Home Contact Us Calendar Advantages Français

ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc. (TSX-PLI.SV) is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary enabling technology, the Mimetic Ligand™. This technology is used in large-scale purification of biologics and the elimination of pathogens. ProMetic is also active in Therapeutic Drug Development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of inflammation and cancer. Its drug discovery platform is focussed on replacing complex, expensive proteins with synthetic "drug-like" protein mimetics. Headquartered in Montréal (Canada), ProMetic has R&D and manufacturing facilities in the UK and business development activities in the US, Europe, Asia and MENA countries (Middle East and North Africa).


Investor Relations

Dominic Sicotte, President
Echoes Financial Network Inc.,
(514) 842-9551;
(866) 663-9551


Please send me ProMetic Life Sciences Inc. News Alert.
Company's Focus

For Informations , please click here
Autoimmune disease
Recombinant proteins

Year End

Date of ListingJuly 28th, 1998
Financial Year-End:December 31

Annual Report

Annual report 2007  Annual report , 2006  

Management Team

Board o directors:

Pierre Laurin, B.Sc.Pharm., M.Sc. »
Président o management, président & chef of directors
ProMetic Sciences de la vie inc.

Bruce Pritchard, BA, CA, MloD »
Chef of financial management
ProMetic Sciences de la vie inc.

Patrick Sartore. B.Sc., LL.B. »
Conseiller juridique principal, PI et
Secrétaire corporatif
ProMetic Sciences de la vie inc.

Christopher L. Penney, Ph.D. »
Chef de la direction scientifique, thérapeutique
ProMetic BioSciences Inc.

Steven J. Burton, Ph.D. »
Chef de la direction
ProMetic BioSciences Ltd

Management :

Pierre Laurin »
Président du conseil d’adminstration,
président et chef de la direction
ProMetic Sciences de la vie inc.

G.F. Kym Anthony
Président suppléant du conseil
Mackie Research Capital Corporation
Siège présidentiel
DFG Investment Advisers

Robert Lacroix »

Premier vice-président
CTI Capital Valeurs Mobilières inc.

Louise Ménard »

Groupe Méfor inc.

Paul Mesburis »
Gestionnaire de portefeuille principal et
chef de vérification de la conformité
Excel Investment Counsel Inc.

Nancy Orr »


Louise Paradis »
Première vice-présidente, affaires juridiques et secrétaire générale
Banque de développement du Canada

Roger Perrault »

Administrateur de sociétés

Bruce Wendel »
Vice-président du conseil et
chef de la direction
Abraxis BioScience

Benjamin Wygodny »

Angus Partnership Inc.

Ask your questions

Ask your question about ProMetic here

Order directly here

Annual Report
Investor Package
DVD of the presentation


Paradigm Capital Inc.
Claude Camire

* ProMetic has retained the services of Crystal Research Associates for the production of an Executive Informational Overview that is available on their website: www.crystalra.com.

Sedar Link

Click here

Last Conference Call

Q1 2005
Click to play movie
Click to play movie
Click to play movie

Other Videos and pictures